Cargando…
Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
BACKGROUND: Recent studies have shown that inflammatory indicators are closely related to the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful indices for predicting recurrence and survival time after treatment. However, the predictive ability of inflammatory indic...
Autores principales: | Zhao, Dongxu, Xu, Wei, Zhan, Yi, Xu, Lin, Ding, Wenbin, Xu, Aibing, Hou, Zhongheng, Ni, Caifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291869/ https://www.ncbi.nlm.nih.gov/pubmed/37378393 http://dx.doi.org/10.1177/11795549231178178 |
Ejemplares similares
-
Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022) -
Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE
Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective
Study
por: Liu, Shanshan, et al.
Publicado: (2023) -
Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022) -
Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation
por: Wan, Ping, et al.
Publicado: (2014) -
Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
por: Liu, Ze-Long, et al.
Publicado: (2021)